This presentation discusses the role of pharmacists and introduces the concept of a "Seven-Star Pharmacist". It outlines the seven roles a pharmacist should fulfill: caregiver, decision-maker, communicator, manager, lifelong learner, teacher, and leader. For each role, the presentation provides examples of responsibilities and skills pharmacists need to effectively serve patients and the healthcare system. The overarching message is that pharmacists must embrace all seven roles to achieve the World Health Organization's vision of an ideal "Seven-Star Pharmacist".
Pharmacovigilanc: The science & activities relating to the Detection, Assessment, Understanding and Prevention of adverse effects or any other drug related problems
The Thalidomide Tragedy (Lessons for Drug Safety and Regulation)
CLASSIFICATION OF ADRS (RAWLIN AND THOMPSON CLASSIFICATION)
Why PV is Necessary?
Objective of PV
Outcomes of Drugs
Causal Relationship
Adverse drug reaction and causality assessment scales
Classification of AE
Serious Adverse Event (SAE)
Sources of Adverse Events (AE) reports
Sources of AE Reports(Solicited Reports)
What to Report?
Who to Report?
When to Report?
Individual case data flow
Pharmacovigilanc: The science & activities relating to the Detection, Assessment, Understanding and Prevention of adverse effects or any other drug related problems
The Thalidomide Tragedy (Lessons for Drug Safety and Regulation)
CLASSIFICATION OF ADRS (RAWLIN AND THOMPSON CLASSIFICATION)
Why PV is Necessary?
Objective of PV
Outcomes of Drugs
Causal Relationship
Adverse drug reaction and causality assessment scales
Classification of AE
Serious Adverse Event (SAE)
Sources of Adverse Events (AE) reports
Sources of AE Reports(Solicited Reports)
What to Report?
Who to Report?
When to Report?
Individual case data flow
Introduction to Clinical Pharmacy Practice.pptxSHIVANEE VYAS
Clinical pharmacy is a branch of hospital pharmacy that deals with various aspects of patient care, including the dispensing of drugs and advising the patient on the safe and rational use of those drugs.
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Therapeutic Drug Monitoring (TDM) is important tool to identify the drug concentration for their therapeutic range to minimize unwanted effects of particular drugs
The Investigator's Brochure (IB) is a comprehensive document summarizing the body of information about an investigational product (IB) obtained during a drug trial.
Adverse Drug Reactions (ADR)- Ravinandan A PRavinandan A P
The World Health Organization (WHO) defines an adverse drug reaction (ADR) as “any response to a drug which is noxious (harmful/toxic), unintended, and which occurs at doses normally used in man for prophylaxis, diagnosis or therapy of a disease, or for the modification of physiological function ".
Spontenous adr reporting in india
PASSIVE survillence system, data assement
data aciqsition, data interpretation, what all information required in ADR form, WHEN TO REPORT
BLUE CARD,YELLOW CARD, WHO CODES
Lab Results Interpretation for Pharmacist A.NouriAhmed Nouri
PHARMACISTS dealing with LAB RESULTS reading, each pharmacist needs to have the basic knowledge regarding lab results and how to deal with it . Ahmed Nouri, PharmD
Concept of Pharmacovigilance, history and development of pharmacovigilance, WHO International drug monitoring programme, Pharmacovigilance programme of India
Unit 1 Hospital by Ravinandan A P 2022 RaviNandan27
Hospital Definition, Classification of hospital- Primary, Secondary and Tertiary hospitals, Classification based on clinical and non- clinical basis, Organization Structure of a Hospital
Introduction to Clinical Pharmacy Practice.pptxSHIVANEE VYAS
Clinical pharmacy is a branch of hospital pharmacy that deals with various aspects of patient care, including the dispensing of drugs and advising the patient on the safe and rational use of those drugs.
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Therapeutic Drug Monitoring (TDM) is important tool to identify the drug concentration for their therapeutic range to minimize unwanted effects of particular drugs
The Investigator's Brochure (IB) is a comprehensive document summarizing the body of information about an investigational product (IB) obtained during a drug trial.
Adverse Drug Reactions (ADR)- Ravinandan A PRavinandan A P
The World Health Organization (WHO) defines an adverse drug reaction (ADR) as “any response to a drug which is noxious (harmful/toxic), unintended, and which occurs at doses normally used in man for prophylaxis, diagnosis or therapy of a disease, or for the modification of physiological function ".
Spontenous adr reporting in india
PASSIVE survillence system, data assement
data aciqsition, data interpretation, what all information required in ADR form, WHEN TO REPORT
BLUE CARD,YELLOW CARD, WHO CODES
Lab Results Interpretation for Pharmacist A.NouriAhmed Nouri
PHARMACISTS dealing with LAB RESULTS reading, each pharmacist needs to have the basic knowledge regarding lab results and how to deal with it . Ahmed Nouri, PharmD
Concept of Pharmacovigilance, history and development of pharmacovigilance, WHO International drug monitoring programme, Pharmacovigilance programme of India
Unit 1 Hospital by Ravinandan A P 2022 RaviNandan27
Hospital Definition, Classification of hospital- Primary, Secondary and Tertiary hospitals, Classification based on clinical and non- clinical basis, Organization Structure of a Hospital
Introduction to Clinical Pharmacy Practice, Definitions and Aim, Objectives, Scopes or services of Clinical Pharmacy, Functions and Roles of Clinical Pharmacy, Qualities of Clinical Pharmacy.
Clinical pharmacy may be defined as the science and practice of rationale use of
medications, where the pharmacists are more oriented towards the patient care
rationalizing medication therapy promoting health , wellness of people.
It is the modern and extended field of pharmacy.
“ The discipline that embodies the application and development (by pharmacist) of
scientific principles of pharmacology, toxicology, therapeutics, and clinical pharmacokinetics, pharmacoeconomics, pharmacogenomics and other allied
sciences for the care of patients”.
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
b) Clinical Pharmacy
Introduction to Clinical Pharmacy, Concept of clinical pharmacy
Functions and responsibilities of clinical pharmacist, Drug therapy monitoring
Medication chart review, clinical review., pharmacist intervention
Ward round participation, Medication history and Pharmaceutical care.
Dosing pattern and drug therapy based on Pharmacokinetic & disease pattern
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
1. Presented by,
Dr. Sam Aaseer Thamby, M.Pharm, PhD (Clinical Pharmacy)
Asst. Professor,
Faculty of Pharmacy,
Dept. of Clinical Pharmacy & Pharmacy Practice
AIMST University, Malaysia
2.
3. Contents Of The Presentation
Introduction (Health, Pharmacist’s roles)
Pharmaceutical Care
SEVEN-STAR PHARMACIST
CARE-GIVER
DECISION MAKER
COMMUNICATOR
MANAGER
LIFE-LONG LEARNER
TEACHER
LEADER
4. What is Health???
A state of complete physical, mental and social well-
being, not merely the absence of disease or infirmity.
(WHO,1946)
The PHARMACIST….
Is the Medications Expert;
‘A qualified person who formulates, dispenses, and
provides clinical services and information on drugs
(medications) to health professionals, patients, and
the general public.’
6. Practice of pharmacy has changed significantly in recent
years.
PHARMACIST’S ROLES:
From ‘compounder’ or ‘chemist’ to ‘DRUG THERAPY
MANAGER’.
From pre-clinical to clinical aspects (drug dispensing,
patient education, patient counseling, hospital/pharmacy
administration and community services, manufacturing,
quality control, regulatory roles);
7. PHARMACEUTICAL CARE (Hepler & Strand -1990)
Embodies a patient-centric, outcomes-oriented practice
of pharmaceutical care;
The pharmacist – key member of the healthcare team, with
responsibility for medication therapy outcomes;
Pharmaceutical care delivered by Pharmacists…
• is key to the effective, rational and safe use of
medications;
• optimizes patient outcomes;
• has shifted substantially toward the utilization of
pharmaceutical knowledge in the rational use of
medications by the patient.
8. To be effective health care team members, pharmacists
need skills and attitudes enabling them to assume many
different functions.
The concept of the ‘SEVEN-STAR PHARMACIST” was
introduced by the World Health Organization (WHO) in
March 2014 and covered 7 roles.
9.
10. 1. CAREGIVER
2 ‘Musts’….
• provide pharmaceutical services of the highest quality, and
• view their practice as integrated with those of the health
care system and other health professionals.
The pharmacist is the right healthcare personnel to
address any medication issues (as they have the most in-
depth pharmacotherapy knowledge and experience).
11. Caregiver (contd’.)
Can identify duplicative drugs or potential safety issues
associated with drug interactions.
Pharmacists are trained to develop and monitor rational,
effective drug therapy regimens (resulting in decreasing
medication-related errors).
Patient Counselling (to ensure medication adherence).
12. 2. DECISION-MAKER
Take accurate decisions regarding appropriate, efficacious,
safe, and cost-effective use of resources (e.g., personnel,
medications, chemicals, equipment, procedures, and
practice protocols).
Also play a pivotal role in setting medicines policy both at
the local and national levels.
The pharmacist must possess the ability to evaluate
medications’ data and information, and decide upon the
most appropriate course of action.
13. Decision-maker (contd’.)
Decisions are made during/while/when…
• patient assessment, prescription filling, dispensing
medication(s); counselling the patient, monitoring
therapy;
• determining whether follow-up and/or monitoring is
appropriate;
• evaluating drug therapy effectiveness;
• creating documentation;
15. 3. COMMUNICATOR
Is a link between physicians, patients, and other health
care professionals;
Must possess complete updated knowledge about all the
medications;
Be confident (while communicating with patients and other
health care professionals);
Must possess effective patient communication skills;
17. 4. MANAGER
Must possess the ability to manage the natural and
commercial resources (incl. man power, physical, and
financial resources).
Must assume greater responsibility for managing drug label
information;
Ensure the quality of pharmaceutical care; and
Maintain clinical competency in patient care;
18. Manager (contd’.)
Developing and maintaining….
• department policies and procedures,
• goals, objectives of each pharmaceutical service provided,
• QA (quality assurance) programs,
• safety, environmental, and infection control standards
19. 5. LIFE-LONG LEARNER
‘3 Musts’….
• begin while attending college/university;
• be continued throughout the pharmacist’s career.
• regularly update their knowledge and skills (to be updated
with current trends in issues-related to drug therapy
management).
20.
21. Life-long learner (contd’.)
Continuing Professional Development - the lifelong process
of active participation in learning activities that assists
individuals in developing and maintaining continuing
competence, enhancing their professional practice, and
supporting achievement of their career goals.”
(ACPE)Accreditation Council for Pharmacy Education
Continuous education system – structured education (to
support the continuing development to maintain and
enhance the competence).
Pharmacists also develop and maintain proficiency in
delivering patient-centered care; working as part of
interdisciplinary teams; practicing evidence-based medicine
and focusing on quality improvement.
22. 6. TEACHER
One of the pharmacist’s responsibilities is to assist with the
education and training of future generations of pharmacists
and the general public.
The dynamic mode of ‘pharmacy teaching’ offers an
opportunity for professionals to gain new knowledge and
to fine-tune their existing skills.
23. Teacher (contd’.)
The teaching sessions are best conducted in actual
practice settings, where the emerging pharmacists can
immerse themselves in a real-world pharmacy practice
experience.
The student pharmacist must also gain knowledge on
pharmacy laws and regulations to improve the professional
pharmacists’ competencies.
24. 7. LEADER
A leader …
• Creates an idea/vision and motivates other team
members to achieve that vision;
• Continually encourages constructive differences;
• Is ‘mission-driven’ without being egocentric;
• Makes decisions, communicates, and manages the team
effectively.
25. Leader (contd’.)
Pharmacy is at the heart of the healthcare system;
Pharmacists play a vital role in patient healthcare, patient
education and counseling.
Effective pharmacy leaders are experts in demonstrating
and creating high-performance pharmacy practices
characterized by the high-quality patient care, improved
medication safety, and maximum productivity.
26. In Conclusion….
We pharmacists, must be proud of ourselves, to be
an integral part of the healthcare system, and
practice our profession in a highly professional
manner to fulfill the requirement of WHO to
emerge as ‘SEVEN-STAR PHARMACISTS’.
28. REFERENCES
Pharmacy: A look back at the past and a vision for the future. Pharmacy history. Ch.
Available from: http://www.psa.org.au/history-2/chapter-1-pharmacy-a-look-back-
at-the-past-and-a-vision-for-the-future.
Bender GA. „A History of Pharmacy in Pictures‟taken from the book “Great
Moments in Pharmacy”. Available from:
http://www.pharmacy.wsu.edu/history/a%20
history%20of%20pharmacy%20in%20pictures.pdf.
Alabid AH, Ibrahim MI, Hassali MA. Do professional practices among Malaysian
private healthcare providers differ? A comparative study using simulated patients. J
Clin Diagn Res 2013;7:2912-6.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care.
Am J Hosp Pharm 1990;47:533-43.
The Role of the Pharmacist in the Health Care System. Available from:
http://www.apps.who.int/medicinedocs/en/d/Jh2995e/1.5.html.
The Role of the Pharmacist in the Health Care System. Preparing the Future
Pharmacist: Curricular Development. Report of the Third WHO Consultative Group
on the Role of the Pharmacist, Vancouver, Canada, 27-29 August 1997. Geneva:
World Health Organization; 1997. Document no.WHO/PHARM/97/599. Available
from: http://www.who.int/medicines/.
Continuing Professional Development. Available from:
http://www.acpeaccredit.org/ceproviders/CPD.asp.
2001 ASHP Leadership Conference on Pharmacy Practice Management Executive
Summary. From management to leadership: The building blocks of professionalism.
Am J Health Syst Pharm 2002;59:661.